Estrogen receptor-α promoter methylation is a biomarker for outcome prediction of cisplatin resistance in triple-negative breast cancer

A number of previous studies have indicated the presence of a link between estrogen receptor-α (ERα) methylation and triple-negative breast cancer (TNBC). However, the association between ERα methylation and drug resistance during the treatment of TNBC remains unclear. Methylation-specific polymeras...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Junnan, Sun, Tao, Guo, Xiangyu, Wang, Yan, Jing, Mingxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778783/
https://www.ncbi.nlm.nih.gov/pubmed/29456719
http://dx.doi.org/10.3892/ol.2017.7637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778783/
https://www.ncbi.nlm.nih.gov/pubmed/29456719
http://dx.doi.org/10.3892/ol.2017.7637

Ejemplares similares